Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)

Novolog (Pharm-Up 1966) Revenue

Novolog (Pharm-Up 1966) had revenue of 505.83M ILS in the quarter ending March 31, 2026, a decrease of -0.20%. This brings the company's revenue in the last twelve months to 1.80B, down -13.01% year-over-year. In the year 2025, Novolog (Pharm-Up 1966) had annual revenue of 1.81B, down -10.70%.

• Revenue (ttm): 1.80B
• Revenue Growth: -13.01%
• P/S Ratio: 0.26
• Revenue / Employee: 1.97M
• Employees: 916
• Market Cap: 471.03M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.81B	-216.22M	-10.70%
Dec 31, 2024	2.02B	378.11M	23.01%
Dec 31, 2023	1.64B	135.54M	8.99%
Dec 31, 2022	1.51B	252.70M	20.13%
Dec 31, 2021	1.26B	121.61M	10.73%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 31, 2026

Data Sources Report a data error